Evidence map›Paper›PMID 18075753›Full record

ReviewHistochemistry and cell biology2008

Protein quality control: the who's who, the where's and therapeutic escapes.

Jürgen Roth, Gary Hin-Fai Yam, Jingyu Fan, Kiyoko Hirano, Katarina Gaplovska-Kysela, Valerie Le Fourn, Bruno Guhl, Roger Santimaria, Tania Torossi, Martin Ziak and 1 more

Abstract readReview
In one paragraph

Review in Histochemistry and cell biology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Gene therapy for misfolding protein diseases of the central nervous system.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2013
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. The mammalian centrosome and its functional significance.Histochemistry and cell biology · 2008
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jürgen RothDivision of Cell and Molecular Pathology, Department of Pathology, University of Zurich, 8091 Zurich, Switzerland. jurgen.roth@bluewin.ch
Gary Hin-Fai Yam
Jingyu Fan
Kiyoko Hirano
Katarina Gaplovska-Kysela
Valerie Le Fourn
Bruno Guhl
Roger Santimaria
Tania Torossi
Martin Ziak
Christian Zuber

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In cells the quality of newly synthesized proteins is monitored in regard to proper folding and correct assembly in the early secretory pathway, the cytosol and the nucleoplasm. Proteins recognized as non-native in the ER will be removed and degraded by a process termed ERAD. ERAD of aberrant proteins is accompanied by various changes of cellular organelles and results in protein folding diseases. This review focuses on how the immunocytochemical labeling and electron microscopic analyses have helped to disclose the in situ subcellular distribution pattern of some of the key machinery proteins of the cellular protein quality control, the organelle changes due to the presence of misfolded proteins, and the efficiency of synthetic chaperones to rescue disease-causing trafficking defects of aberrant proteins.

Indexed as

Protein FoldingDrug DesignEndoplasmic ReticulumHumansMembrane ProteinsMetabolism, Inborn ErrorsMolecular ChaperonesProteinsEDEM1 protein, humanMembrane ProteinsMolecular ChaperonesProteins

Identifiers

PMID18075753
PMCPMC2228381

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.